Perrigo (PRGO) Net Cash Flow (2013 - 2026)
Perrigo (PRGO) posted quarterly Net Cash Flow of -$171.3 million for Q1 2026, down 12.7% year-over-year from -$196.2 million in Q1 2025, and down 277.51% quarter-over-quarter from $96.5 million in Q4 2025.
Perrigo (PRGO) Net Cash Flow (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Net Cash Flow for 14 consecutive years, with -$171.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 12.7% year-over-year to -$171.3 million; the TTM figure through Mar 2026 stood at -$76.7 million (up 67.5% YoY), while the FY2025 annual figure was -$57.4 million, up 66.1% from the prior year.
- Net Cash Flow retreated to -$171.3 million in Q1 2026 per PRGO's latest filing, from $96.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $908.2 million in Q3 2024 and bottomed at -$1.4 billion in Q3 2022.
- Historically, Net Cash Flow has averaged -$87.5 million across 5 years, with a median of -$4.7 million in 2022.
- On a YoY basis, Net Cash Flow climbed as much as 1698.42% in 2024 and fell as far as 113500.0% in 2024.
- Perrigo's Net Cash Flow stood at $117.4 million in 2022, then advanced by 20.36% to $141.3 million in 2023, then plunged by 721.8% to -$878.6 million in 2024, then surged by 110.98% to $96.5 million in 2025, then tumbled by 277.51% to -$171.3 million in 2026.
- Business Quant data shows PRGO's Net Cash Flow at -$171.3 million in Q1 2026, $96.5 million in Q4 2025, and -$20.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.87 Bn | 40.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.16 Bn | 30.48 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Perrigo | 1.92 Bn | 1.52 Bn | 313.90 Mn | 43.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 43.10 Mn |
| Jun 27, 2026 | 43.10 Mn |
| Mar 28, 2026 | -171.30 Mn |
| Mar 28, 2026 | -171.30 Mn |
| Dec 31, 2025 | 96.50 Mn |
| Dec 31, 2025 | 96.50 Mn |
| Sep 27, 2025 | -20.00 Mn |
| Sep 27, 2025 | -20.00 Mn |
| Jun 28, 2025 | 18.10 Mn |
| Jun 28, 2025 | 18.10 Mn |
| Mar 29, 2025 | -152.00 Mn |
| Mar 29, 2025 | -152.00 Mn |
| Dec 31, 2024 | -878.60 Mn |
| Dec 31, 2024 | -878.60 Mn |
| Sep 28, 2024 | 908.20 Mn |
| Sep 28, 2024 | 908.20 Mn |
| Jun 29, 2024 | -113.60 Mn |
| Jun 29, 2024 | -113.60 Mn |
| Mar 30, 2024 | -85.30 Mn |
| Mar 30, 2024 | -85.30 Mn |